Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam.

NCT02233972 is registered in ClinicalTrials.gov with Jiangsu Kanion Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT02233972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02233972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam.
Lead sponsor
Jiangsu Kanion Pharmaceutical Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2014
Completion date
Not reported
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics